{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:52:18Z","timestamp":1788922338942,"version":"build-2803163510"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine and Research"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.resmer.2024.101128","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T22:30:53Z","timestamp":1720305053000},"page":"101128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Dual inhaled antibiotics for treatment of pulmonary exacerbations in cystic fibrosis \u2013 A real life pilot study"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8073-3973","authenticated-orcid":false,"given":"Moshe","family":"Heching","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liora","family":"Slomianksy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda","family":"Mussaffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Prais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mordechai R.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.resmer.2024.101128_bib0001","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jcf.2024.01.005","article-title":"Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues","volume":"23","author":"Burgel","year":"2024","journal-title":"J Cyst Fibros"},{"issue":"9","key":"10.1016\/j.resmer.2024.101128_bib0002","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","article-title":"Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations","volume":"180","author":"Flume","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.resmer.2024.101128_bib0003","article-title":"Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis","volume":"8","author":"Smith","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.resmer.2024.101128_bib0004","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/ppul.22652","article-title":"Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis","volume":"48","author":"Wagener","year":"2013","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.resmer.2024.101128_bib0005","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.12688\/f1000research.13298.1","article-title":"Case Report: dual nebulized antibiotics among adults with cystic fibrosis and chronic Pseudomonas infection","volume":"6","author":"Mann","year":"2017","journal-title":"F1000Res"},{"issue":"6","key":"10.1016\/j.resmer.2024.101128_bib0006","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jcf.2020.12.012","article-title":"The clinical and microbiological utility of inhaled aztreonam lysine for the treatment of acute pulmonary exacerbations of cystic fibrosis: an open-label randomized crossover study (AZTEC-CF)","volume":"20","author":"Frost","year":"2021","journal-title":"J. Cyst. Fibros."},{"issue":"167","key":"10.1016\/j.resmer.2024.101128_bib0007","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1183\/16000617.0154-2022","article-title":"Role of inhaled antibiotics in the era of highly effective CFTR modulators","volume":"32","author":"Elborn","year":"2023","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.resmer.2024.101128_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2023.11.012","article-title":"Inhaled antimicrobial prescribing for Pseudomonas aeruginosa infections in Europe","author":"Sloan","year":"2024","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.resmer.2024.101128_bib0009","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/17425255.2021.1836157","article-title":"The pharmacokinetics of antibiotics in cystic fibrosis","volume":"17","author":"Akkerman-Nijland","year":"2021","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"4","key":"10.1016\/j.resmer.2024.101128_bib0010","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s40262-020-00981-0","article-title":"Pharmacokinetic and pharmacodynamic optimization of antibiotic therapy in cystic fibrosis patients: current evidences, gaps in knowledge and future directions","volume":"60","author":"Magr\u00e9ault","year":"2021","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"10.1016\/j.resmer.2024.101128_bib0011","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1513\/AnnalsATS.201311-395FR","article-title":"Inhaled antibiotics for lower airway infections","volume":"11","author":"Quon","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"10","key":"10.1016\/j.resmer.2024.101128_bib0012","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1164\/rccm.201312-2161OC","article-title":"Reduction of bacterial resistance with inhaled antibiotics in the intensive care unit","volume":"189","author":"Palmer","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.resmer.2024.101128_bib0013","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1378\/chest.122.1.219","article-title":"Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis","volume":"122","author":"Geller","year":"2002","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.resmer.2024.101128_bib0014","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jcf.2016.10.003","article-title":"Improving inhaled antibiotic treatment - Practice defeats the proof","volume":"15","author":"van der Ent","year":"2016","journal-title":"J Cyst Fibros"},{"issue":"11","key":"10.1016\/j.resmer.2024.101128_bib0015","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1016\/j.xphs.2017.06.010","article-title":"Population pharmacokinetics of tobramycin inhalation solution in pediatric patients with cystic fibrosis","volume":"106","author":"Wang","year":"2017","journal-title":"J Pharm Sci"}],"container-title":["Respiratory Medicine and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041224000448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041224000448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T08:04:30Z","timestamp":1734163470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590041224000448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":15,"alternative-id":["S2590041224000448"],"URL":"https:\/\/doi.org\/10.1016\/j.resmer.2024.101128","relation":{},"ISSN":["2590-0412"],"issn-type":[{"value":"2590-0412","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual inhaled antibiotics for treatment of pulmonary exacerbations in cystic fibrosis \u2013 A real life pilot study","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine and Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resmer.2024.101128","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"101128"}}